Suppr超能文献

抗菌组合对浮游菌和生物被膜形式的活性。 (原文句子似乎不完整,缺少具体针对的菌种等信息)

activities of antimicrobial combinations against planktonic and biofilm forms of .

作者信息

Su Bo-An, Chen Chi-Chung, Chen Hung-Jui, Lai Hsin-Yu, Tsai Chia-Hung, Lai Chih-Cheng, Tang Hung-Jen, Chao Chien-Ming

机构信息

Division of Infectious Diseases, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan.

Department of Pharmacy, Chia Nan University of Pharmacy and Science, Tainan, Taiwan.

出版信息

Front Microbiol. 2023 Jun 20;14:1186669. doi: 10.3389/fmicb.2023.1186669. eCollection 2023.

Abstract

OBJECTIVES

To investigate the activity of antibiotic combinations against isolates and their associated biofilms.

METHODS

Thirty-two clinical isolates with at least twenty-five different pulsotypes were tested. The antibacterial activity of various antibiotic combinations against seven randomly selected planktonic and biofilm-embedded strains with strong biofilm formation was assessed using broth methods. Extraction of bacterial genomic DNA and PCR detection of antibiotic resistance and biofilm-related genes were also performed.

RESULTS

The susceptibility rates of levofloxacin (LVX), fosfomycin (FOS), tigecycline (TGC) and sulfamethoxazole-trimethoprim (SXT) against 32 isolates were 56.3, 71.9, 71.9 and 90.6%, respectively. Twenty-eight isolates were detected with strong biofilm formation. Antibiotic combinations, including aztreonam-clavulanic (ATM-CLA) with LVX, ceftazidime-avibactam (CZA) with LVX and SXT with TGC, exhibited potent inhibitory activity against these isolates with strong biofilm formation. The antibiotic resistance phenotype might not be fully caused by the common antibiotic-resistance or biofilm-formation gene.

CONCLUSION

remained resistant to most antibiotics, including LVX and β-lactam/β-lactamases; however, TGC, FOS and SXT still exhibited potent activity. Although all tested isolates exhibited moderate-to-strong biofilm formation, combination therapies, especially ATM-CLA with LVX, CZA with LVX and SXT with TGC, exhibited a higher inhibitory activity for these isolates.

摘要

目的

研究抗生素联合用药对分离株及其相关生物膜的活性。

方法

对32株具有至少25种不同脉冲型的临床分离株进行检测。采用肉汤法评估各种抗生素联合用药对7株随机选择的浮游菌和生物膜包被的、具有较强生物膜形成能力的菌株的抗菌活性。还进行了细菌基因组DNA的提取以及抗生素耐药性和生物膜相关基因的PCR检测。

结果

左氧氟沙星(LVX)、磷霉素(FOS)、替加环素(TGC)和磺胺甲恶唑-甲氧苄啶(SXT)对32株分离株的敏感率分别为56.3%、71.9%、71.9%和90.6%。检测到28株具有较强生物膜形成能力的分离株。抗生素联合用药,包括氨曲南-克拉维酸(ATM-CLA)与LVX、头孢他啶-阿维巴坦(CZA)与LVX以及SXT与TGC,对这些具有较强生物膜形成能力的分离株表现出强大的抑制活性。抗生素耐药表型可能并非完全由常见的抗生素耐药或生物膜形成基因引起。

结论

对包括LVX和β-内酰胺/β-内酰胺酶在内的大多数抗生素仍有耐药性;然而,TGC、FOS和SXT仍表现出强大的活性。尽管所有测试的分离株均表现出中度至强的生物膜形成能力,但联合治疗,尤其是ATM-CLA与LVX、CZA与LVX以及SXT与TGC,对这些分离株表现出更高的抑制活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1a0/10319008/0d7b4c749458/fmicb-14-1186669-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验